Canabidiol may inhibit bile duct cancer, Thai study finds

A recent Thai study published in the Journal of Traditional and Complementary Medicine revealed that cannabidiol (CBD) may be a promising therapeutic alternative for the treatment of cholangiocarcinoma (CCA), an aggressive type of bile duct cancer, which is a long tube connected to the liver that carries bile. The research showed that CBD inhibits cell proliferation, induces autophagy and senescence, and promotes cell death, also known as apoptosis, through modulation of the PI3K/AKT/mTOR pathway.

How does CBD act on cholangiocarcinoma?

Cholangiocarcinoma is a type of cancer that affects the bile ducts, channels responsible for transporting bile from the liver to the intestine. As it is often diagnosed in advanced stages, treatment options are limited. In the study, scientists analyzed the effect of CBD on three different types of tumor cells and also in animal models. The results indicated that the substance significantly reduced the growth of cancer cells.

CBD demonstrated an important effect by inducing cellular senescence. This process occurs when cells enter a state of aging, losing the ability to multiply. This prevents the tumor from continuing to grow. Additionally, autophagy activation was observed, a mechanism by which the cell recycles damaged internal components. Although this process is normally beneficial for the cell, in the case of cancer, it can be used to eliminate defective tumor cells.

The importance of the PI3K/AKT/mTOR pathway in cancer

One of the most relevant findings of the study was the action of CBD on the PI3K/AKT/mTOR pathway, one of the main molecular pathways involved in the proliferation and survival of tumor cells. This pathway functions as a "switch" that regulates cell growth. In cancer, it is often hyperactivated, allowing cells to multiply rapidly. CBD was able to suppress this pathway, reducing the ability of cancer cells to survive.

Researchers also observed an increase in the expression of proteins that help control cell growth, such as p53 and p21. These proteins act as "brakes" for uncontrolled cell division, a major issue in cancer. Additionally, a reduction in the PCNA protein, which is directly linked to tumor cell proliferation, was detected.

Promising results in animal models

In addition to tests on cells cultured in the laboratory, the study also evaluated the effects of CBD on mice with cholangiocarcinoma tumors. In animals treated with the substance, there was a significant reduction in tumor size compared to those that did not receive the treatment. This finding suggests that CBD may have real therapeutic applications and not just effects observed in a controlled laboratory environment.

Another important point was the finding that CBD induced changes in the structure of tumor cells, making them more susceptible to cell death. The mitochondrial dysfunction observed in treated tumors indicates that the metabolism of cancer cells was affected, hindering their survival. This type of approach is promising because it targets cancer in different ways, increasing the chance of treatment success.

Possibilities for future treatments

The study results suggest that CBD may be a candidate for future combined therapies against cholangiocarcinoma. However, researchers caution that more studies are needed to fully understand its effects and ensure its safety. The research paves the way for clinical trials in humans, which will be crucial to confirm the substance's effectiveness and define the optimal dosage for treatment.

If clinical trials are successful, CBD could be incorporated into existing therapies for cholangiocarcinoma, improving treatment options for patients. Currently, the main approaches include surgery, chemotherapy, and targeted therapies, but the success rate is still limited, especially in advanced cases. The possibility of using cannabidiol as a complementary treatment brings hope to improve patient survival and quality of life.

With the growing interest in the therapeutic properties of cannabidiol, research like this reinforces the need for more investments in the study of cannabinoids. Discovering new mechanisms of action of CBD may open doors for its application in other types of cancer, as well as contribute to the advancement of personalized medicine.